91 related articles for article (PubMed ID: 24524690)
41. Discovery of Potent Succinate-Ubiquinone Oxidoreductase Inhibitors via Pharmacophore-linked Fragment Virtual Screening Approach.
Xiong L; Zhu XL; Gao HW; Fu Y; Hu SQ; Jiang LN; Yang WC; Yang GF
J Agric Food Chem; 2016 Jun; 64(24):4830-7. PubMed ID: 27225833
[TBL] [Abstract][Full Text] [Related]
42. Discovery of the first inhibitors of bacterial enzyme D-aspartate ligase from Enterococcus faecium (Aslfm).
Škedelj V; Perdih A; Brvar M; Kroflič A; Dubbée V; Savage V; O'Neill AJ; Solmajer T; Bešter-Rogač M; Blanot D; Hugonnet JE; Magnet S; Arthur M; Mainardi JL; Stojan J; Zega A
Eur J Med Chem; 2013 Sep; 67():208-20. PubMed ID: 23867605
[TBL] [Abstract][Full Text] [Related]
43. Pharmacophore identification and virtual screening for methionyl-tRNA synthetase inhibitors.
Bharatham N; Bharatham K; Lee KW
J Mol Graph Model; 2007 Mar; 25(6):813-23. PubMed ID: 16996282
[TBL] [Abstract][Full Text] [Related]
44. Identification of novel nematode succinate dehydrogenase inhibitors: Virtual screening based on ligand-pocket interactions.
Xu Q; Zhao Z; Liang P; Wang S; Li F; Jin S; Zhang J
Chem Biol Drug Des; 2023 Jan; 101(1):9-23. PubMed ID: 34981652
[TBL] [Abstract][Full Text] [Related]
45. Pharmacophore modelling and virtual screening for identification of new Aurora-A kinase inhibitors.
Deng XQ; Wang HY; Zhao YL; Xiang ML; Jiang PD; Cao ZX; Zheng YZ; Luo SD; Yu LT; Wei YQ; Yang SY
Chem Biol Drug Des; 2008 Jun; 71(6):533-9. PubMed ID: 18410307
[TBL] [Abstract][Full Text] [Related]
46. Pharmacophore-based virtual screening: the discovery of novel methionyl-tRNA synthetase inhibitors.
Kim SY; Lee YS; Kang T; Kim S; Lee J
Bioorg Med Chem Lett; 2006 Sep; 16(18):4898-907. PubMed ID: 16824759
[TBL] [Abstract][Full Text] [Related]
47. Molecular dynamics-based discovery of novel phosphodiesterase-9A inhibitors with non-pyrazolopyrimidinone scaffolds.
Li Z; Lu X; Feng LJ; Gu Y; Li X; Wu Y; Luo HB
Mol Biosyst; 2015 Jan; 11(1):115-25. PubMed ID: 25328054
[TBL] [Abstract][Full Text] [Related]
48. Discovery of potential pancreatic cholesterol esterase inhibitors using pharmacophore modelling, virtual screening, and optimization studies.
John S; Thangapandian S; Sakkiah S; Lee KW
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):535-45. PubMed ID: 21143043
[TBL] [Abstract][Full Text] [Related]
49. Discovery of diethyl 2,5-diaminothiophene-3,4-dicarboxylate derivatives as potent anticancer and antimicrobial agents and screening of anti-diabetic activity: synthesis and in vitro biological evaluation. Part 1.
Bozorov K; Ma HR; Zhao JY; Zhao HQ; Chen H; Bobakulov K; Xin XL; Elmuradov B; Shakhidoyatov K; Aisa HA
Eur J Med Chem; 2014 Sep; 84():739-45. PubMed ID: 25064350
[TBL] [Abstract][Full Text] [Related]
50. In silico discovery and biophysical evaluation of novel 5-(2-hydroxybenzylidene) rhodanine inhibitors of DNA gyrase B.
Brvar M; Perdih A; Hodnik V; Renko M; Anderluh G; Jerala R; Solmajer T
Bioorg Med Chem; 2012 Apr; 20(8):2572-80. PubMed ID: 22444877
[TBL] [Abstract][Full Text] [Related]
51. Discovery of non-peptide inhibitors of Plasmepsin II by structure-based virtual screening.
Song Y; Jin H; Liu X; Zhu L; Huang J; Li H
Bioorg Med Chem Lett; 2013 Apr; 23(7):2078-82. PubMed ID: 23466235
[TBL] [Abstract][Full Text] [Related]
52. A new insight into mushroom tyrosinase inhibitors: docking, pharmacophore-based virtual screening, and molecular modeling studies.
Bagherzadeh K; Shirgahi Talari F; Sharifi A; Ganjali MR; Saboury AA; Amanlou M
J Biomol Struct Dyn; 2015; 33(3):487-501. PubMed ID: 24601849
[TBL] [Abstract][Full Text] [Related]
53. Protein Flexibility in Docking-Based Virtual Screening: Discovery of Novel Lymphoid-Specific Tyrosine Phosphatase Inhibitors Using Multiple Crystal Structures.
Hou X; Li K; Yu X; Sun JP; Fang H
J Chem Inf Model; 2015 Sep; 55(9):1973-83. PubMed ID: 26360643
[TBL] [Abstract][Full Text] [Related]
54. Novel small molecule inhibitors targeting the "switch region" of bacterial RNAP: structure-based optimization of a virtual screening hit.
Sahner JH; Groh M; Negri M; Haupenthal J; Hartmann RW
Eur J Med Chem; 2013 Jul; 65():223-31. PubMed ID: 23711833
[TBL] [Abstract][Full Text] [Related]
55. Discovery of novel fatty acid synthase (FAS) inhibitors based on the structure of ketoaceyl synthase (KS) domain.
Zeng XF; Li WW; Fan HJ; Wang XY; Ji P; Wang ZR; Ma S; Li LL; Ma XF; Yang SY
Bioorg Med Chem Lett; 2011 Aug; 21(16):4742-4. PubMed ID: 21752639
[TBL] [Abstract][Full Text] [Related]
56. Structure-based virtual screening as a tool for the identification of novel inhibitors against Mycobacterium tuberculosis 3-dehydroquinate dehydratase.
Petersen GO; Saxena S; Renuka J; Soni V; Yogeeswari P; Santos DS; Bizarro CV; Sriram D
J Mol Graph Model; 2015 Jul; 60():124-31. PubMed ID: 26043661
[TBL] [Abstract][Full Text] [Related]
57. Pharmacophore modeling, virtual screening, molecular docking studies and density functional theory approaches to identify novel ketohexokinase (KHK) inhibitors.
Kavitha R; Karunagaran S; Chandrabose SS; Lee KW; Meganathan C
Biosystems; 2015 Dec; 138():39-52. PubMed ID: 26521124
[TBL] [Abstract][Full Text] [Related]
58. Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screening.
Turk S; Kovac A; Boniface A; Bostock JM; Chopra I; Blanot D; Gobec S
Bioorg Med Chem; 2009 Mar; 17(5):1884-9. PubMed ID: 19223185
[TBL] [Abstract][Full Text] [Related]
59. Discovery of novel inhibitors targeting the macrophage migration inhibitory factor via structure-based virtual screening and bioassays.
Xu L; Zhang Y; Zheng L; Qiao C; Li Y; Li D; Zhen X; Hou T
J Med Chem; 2014 May; 57(9):3737-45. PubMed ID: 24712915
[TBL] [Abstract][Full Text] [Related]
60. Novel broad-spectrum inhibitors of bacterial methionine aminopeptidase.
Rose JA; Lahiri SD; McKinney DC; Albert R; Morningstar ML; Shapiro AB; Fisher SL; Fleming PR
Bioorg Med Chem Lett; 2015 Aug; 25(16):3301-6. PubMed ID: 26099541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]